{"id":"NCT01182376","sponsor":"University of Utah","briefTitle":"SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI","officialTitle":"SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2010-08-16","resultsPosted":"2016-02-19","lastUpdate":"2016-02-19"},"enrollment":33,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation"],"interventions":[{"type":"DRUG","name":"dronedarone","otherNames":["Multaq速"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Multaq速 (dronedarone)","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to demonstrate how dronedarone (Multaq速) may aid in the slowing of progression of left atrial and ventricular fibrosis in patients with atrial fibrillation as assessed by late gadolinium enhanced magnetic resonance imaging.","primaryOutcome":{"measure":"LA Fibrosis","timeFrame":"baseline, 1 year","effectByArm":[{"arm":"Placebo","deltaMin":24.6,"sd":0.07},{"arm":"Multaq速 (Dronedarone)","deltaMin":16.8,"sd":0.05}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["9922372","16510747","15133358","12103262","12505579","15175066","17504254","11714647","16690376","15928285","19307477","19187904","19272055","19371204","18835843"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["non compliance","other surgeries","Nausea","arrhythmias","drug interactions"]}}